Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Kagawa Y, Yamada D, Yamasaki M, et al. The association between the increased performance of laparoscopic colon surgery and a reduced risk of surgical site infection. Surg Today. 2019;49:474–481. doi:10.1007/s00595-019-1760-130684051
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564(7735):268–272. doi:10.1038/s41586-018-0694-x30479382
   PubMed Web of Science ®Google Scholar
• Taucher V, Mangge H, Haybaeck J. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol (Dordr). 2016;39(4):295–318. doi:10.1007/s13402-016-0275-727060060
   PubMed Web of Science ®Google Scholar
• Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 2010;394(3):623–627. doi:10.1016/j.bbrc.2010.03.03620226166
   PubMed Web of Science ®Google Scholar
• Yang B, Gao G, Wang Z, et al. Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging miR-216a-5p. Biosci Rep. 2018;38(5):BSR20180566.29884766
   PubMedGoogle Scholar
• Bai J, Yao B, Wang L, et al. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. J Cell Biochem. 2019;120(6):1–13. doi:10.1002/jcb.28315
   Google Scholar
• Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncol. 2017;31(5):381–389.
   Google Scholar
• Rychahou P, Bae Y, Reichel D, et al. Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles. J Controlled Release. 2018;275:85–91. doi:10.1016/j.jconrel.2018.02.008
   PubMed Web of Science ®Google Scholar
• Huang S, Zou C, Tang Y, et al. miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-beta signaling. Mol Ther Nucleic Acids. 2019;16:91–104. doi:10.1016/j.omtn.2019.01.00430852380
   PubMedGoogle Scholar
• Wu G, Zheng H, Xu J, et al. miR-429 suppresses cell growth and induces apoptosis of human thyroid cancer cell by targeting ZEB1. Artif Cells Nanomed Biotechnol. 2019;47(1):548–554. doi:10.1080/21691401.2018.156432030849921
   PubMed Web of Science ®Google Scholar
• Ren L, Chen H, Song J, et al. MiR-454-3p-mediated Wnt/beta-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics. 2019;9(2):449–465. doi:10.7150/thno.2905530809286
   PubMed Web of Science ®Google Scholar
• Wang T, Chen G, Ma X, et al. MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway. Cell Death Dis. 2019;10(3):153. doi:10.1038/s41419-019-1326-630770779
   PubMedGoogle Scholar
• Nakamura K, Sawada K, Miyamoto M, et al. Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression. Oncotarget. 2019;10(6):673–683. doi:10.18632/oncotarget.2658630774764
   PubMedGoogle Scholar
• Guo W, Chen Z, Chen Z, et al. Promotion of cell proliferation through inhibition of cell autophagy signalling pathway by Rab3IP is restrained by MicroRNA-532-3p in gastric cancer. J Cancer. 2018;9(23):4363–4373. doi:10.7150/jca.2753330519341
   PubMed Web of Science ®Google Scholar
• Wang J, Pu J, Zhang Y, et al. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12. J Cell Physiol. 2019;234(6):9408–9416. doi:10.1002/jcp.2762530430564
   PubMed Web of Science ®Google Scholar
• Liang L, Xu J, Wang M, et al. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. Cell Death Dis. 2018;9(3):372. doi:10.1038/s41419-018-0382-729515098
   PubMed Web of Science ®Google Scholar
• Chen D, Yu D, Wang X, et al. Epithelial to mesenchymal transition is involved in ethanol promoted hepatocellular carcinoma cells metastasis and stemness. Mol Carcinog. 2018;57(10):1358–1370. doi:10.1002/mc.2285030295962
   PubMed Web of Science ®Google Scholar
• Li Z, Huang J, Shen S, et al. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4. J Exp Clin Cancer Res. 2018;37(1):323. doi:10.1186/s13046-018-0984-z30577808
   PubMedGoogle Scholar
• Lin X, Wang S, Sun M, et al. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization. J Hematol Oncol 2019;12(1):20.
   Google Scholar
• Wu Y, Shi W, Tang T, et al. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death Dis. 2019;10(3):176. doi:10.1038/s41419-019-1437-030792382
   PubMedGoogle Scholar
• Shi DM, Li LX, Bian XY, et al. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. J Exp Clin Cancer Res. 2018;37(1):294. doi:10.1186/s13046-018-0957-230486894
   PubMedGoogle Scholar
• Zhou Y, Xu Q, Shang J, Lu L, Chen G. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1alpha signaling. J Cell Physiol. 2019. doi:10.1002/jcp.28418
   Google Scholar
• Pan H, Hong Y, Yu B, Li L, Zhang X. miR-4429 inhibits tumor progression and epithelial-mesenchymal transition via targeting CDK6 in clear cell renal cell carcinoma. Cancer Biother Radiopharm. 2019. doi:10.1089/cbr.2018.2697
   Web of Science ®Google Scholar
• Wang Q, Feng Y, Peng W, et al. Long noncoding RNA Linc02023 regulates PTEN stability and suppresses tumorigenesis of colorectal cancer in a PTEN-dependent pathway. Cancer Lett. 2019. doi:10.1016/j.canlet.2019.02.041
   Web of Science ®Google Scholar
• Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis. Artif Cells Nanomed Biotechnol. 2019;47(1):776–782. doi:10.1080/21691401.2019.157788330856345
   PubMed Web of Science ®Google Scholar
• Yang C, Wang L, Sun J, et al. Identification of long noncoding RNA HERC2P2 as a tumor suppressor in glioma. Carcinogenesis. 2019. doi:10.1093/carcin/bgz043
   Web of Science ®Google Scholar
• Ye ZM, Yang S, Xia YP, et al. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis. 2019;10(2):138. doi:10.1038/s41419-019-1409-430755588
   PubMed Web of Science ®Google Scholar
• Zhou DD, Liu XF, Lu CW. Long non-coding RNA PVT1: emerging biomarker in digestive system cancer. 2017;50(6): e12398. doi:10.1111/cpr.12398
   Google Scholar
• Zhang R, Li J, Yan X, et al. Long noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) promotes colon cancer progression via endogenous sponging miR-26b. Med Sci Monit. 2018;24:8685–8692. doi:10.12659/MSM.91095530504754
   PubMed Web of Science ®Google Scholar
• Kuwano M, Shibata T, Watari K, Ono M. Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer. Cancer Sci. 2019;110:1536–1543. doi:10.1111/cas.2019.110.issue-530903644
   PubMed Web of Science ®Google Scholar
• Yan X, Yan L, Zhou J, et al. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer. Int J Clin Exp Pathol. 2014;7(12):8715–8723.25674237
   PubMed Web of Science ®Google Scholar
• Gopal SK, Greening DW, Mathias RA, et al. YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment. Oncotarget. 2015;6(15):13718–13730. doi:10.18632/oncotarget.376425980435
   PubMedGoogle Scholar
• Ha B, Lee EB, Cui J, Kim Y, Jang HH. YB-1 overexpression promotes a TGF-beta1-induced epithelial-mesenchymal transition via Akt activation. Biochem Biophys Res Commun. 2015;458(2):347–351. doi:10.1016/j.bbrc.2015.01.11425645014
   PubMed Web of Science ®Google Scholar